Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Coustan-Smith

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|October 19, 1999
Mutations in Igalpha (CD79a) result in a complete block in B-cell developmentY Minegishi, E Coustan-Smith, L Rapalus, et al.
Leukemia|June 1, 1993
N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemiaE Coustan-Smith, F G Behm, C A Hurwitz, et al.
American Journal of Hematology|August 1, 1987
In vitro induction of myeloid surface markers in a rare case of acute leukemiaH G Drexler, E Coustan-Smith, S M Gignac, et al.
Genes, Chromosomes & Cancer|January 1, 1992
Karyotype and T-cell receptor expression in T-lineage acute lymphoblastic leukemiaL M Secker-Walker, D Campana, J M Hawkins, et al.
Blood|November 1, 1987
Synergistic action of calcium ionophore A23187 and phorbol ester TPA on B-chronic lymphocytic leukemia cellsH G Drexler, M K Brenner, E Coustan-Smith, et al.
Blood|May 1, 1988
Analysis of signal transduction in B chronic lymphocytic leukemia cellsH G Drexler, M K Brenner, E Coustan-Smith, et al.
British Journal of Cancer|May 1, 1993
Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradicationN K Foreman, D R Rill, E Coustan-Smith, et al.
Leukemia|September 1, 1990
The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative studyD Campana, S Yokota, E Coustan-Smith, et al.
The Journal of Experimental Medicine|January 31, 1998
Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemiaY Minegishi, E Coustan-Smith, Y H Wang, et al.
Clinical and Experimental Immunology|February 1, 1988
Differential expression of MHC class II antigens in chronic B-cell disordersH G Drexler, S M Gignac, M K Brenner, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|October 19, 1999
Mutations in Igalpha (CD79a) result in a complete block in B-cell developmentY Minegishi, E Coustan-Smith, L Rapalus, et al.
Leukemia|June 1, 1993
N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemiaE Coustan-Smith, F G Behm, C A Hurwitz, et al.
American Journal of Hematology|August 1, 1987
In vitro induction of myeloid surface markers in a rare case of acute leukemiaH G Drexler, E Coustan-Smith, S M Gignac, et al.
Genes, Chromosomes & Cancer|January 1, 1992
Karyotype and T-cell receptor expression in T-lineage acute lymphoblastic leukemiaL M Secker-Walker, D Campana, J M Hawkins, et al.
Blood|November 1, 1987
Synergistic action of calcium ionophore A23187 and phorbol ester TPA on B-chronic lymphocytic leukemia cellsH G Drexler, M K Brenner, E Coustan-Smith, et al.
Blood|May 1, 1988
Analysis of signal transduction in B chronic lymphocytic leukemia cellsH G Drexler, M K Brenner, E Coustan-Smith, et al.
British Journal of Cancer|May 1, 1993
Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradicationN K Foreman, D R Rill, E Coustan-Smith, et al.
Leukemia|September 1, 1990
The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative studyD Campana, S Yokota, E Coustan-Smith, et al.
The Journal of Experimental Medicine|January 31, 1998
Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemiaY Minegishi, E Coustan-Smith, Y H Wang, et al.
Clinical and Experimental Immunology|February 1, 1988
Differential expression of MHC class II antigens in chronic B-cell disordersH G Drexler, S M Gignac, M K Brenner, et al.
Pageof 7